Trial intelligence / Profile preview

Pioglitazone + Azilsartan in Type 2 Diabetes

NCT00762736Phase 2Completed

Sponsor
Takeda
Start
Jul 2004
Primary completion
Oct 2005
Modality
Small Molecules
Countries
5
01

Overview

A Phase 2 trial of azilsartan in type 2 diabetes mellitus (T2DM), sponsored by Takeda. Started Jul 2004; status: completed.

02

Drugs

azilsartan
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NCT00762736.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00762736.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call